{"id":5082,"date":"2024-06-19T05:36:00","date_gmt":"2024-06-19T03:36:00","guid":{"rendered":"https:\/\/psiquiatriamadrid.com\/?p=5082"},"modified":"2024-06-20T12:49:39","modified_gmt":"2024-06-20T10:49:39","slug":"sindrome-neuroleptico-maligno-333-92-g21-0","status":"publish","type":"post","link":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/","title":{"rendered":"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0)"},"content":{"rendered":"<p>El <strong>S\u00edndrome Neurol\u00e9ptico Maligno (SNM)<\/strong> es una reacci\u00f3n adversa grave a los medicamentos antipsic\u00f3ticos, caracterizada por hipertermia, rigidez muscular y disfunci\u00f3n auton\u00f3mica severa.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_52 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Contenidos<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\" role=\"button\"><label for=\"item-6abdc36034cb4\" ><span class=\"\"><span style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input aria-label=\"Toggle\" aria-label=\"item-6abdc36034cb4\"  type=\"checkbox\" id=\"item-6abdc36034cb4\"><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#Definicion_y_Criterios_Diagnosticos_del_Sindrome_Neuroleptico_Maligno_segun_el_DSM-5\" title=\"Definici\u00f3n y Criterios Diagn\u00f3sticos del S\u00edndrome Neurol\u00e9ptico Maligno seg\u00fan el DSM-5\">Definici\u00f3n y Criterios Diagn\u00f3sticos del S\u00edndrome Neurol\u00e9ptico Maligno seg\u00fan el DSM-5<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#Etiologia_y_Factores_de_Riesgo_para_Desarrollar_SNM\" title=\"Etiolog\u00eda y Factores de Riesgo para Desarrollar SNM\">Etiolog\u00eda y Factores de Riesgo para Desarrollar SNM<\/a><ul class='ez-toc-list-level-4'><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#Sintomas_Clinicos_y_Diagnostico_del_Sindrome_Neuroleptico_Maligno\" title=\"S\u00edntomas Cl\u00ednicos y Diagn\u00f3stico del S\u00edndrome Neurol\u00e9ptico Maligno\">S\u00edntomas Cl\u00ednicos y Diagn\u00f3stico del S\u00edndrome Neurol\u00e9ptico Maligno<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#Gestion_y_Tratamiento_del_Sindrome_Neuroleptico_Maligno\" title=\"Gesti\u00f3n y Tratamiento del S\u00edndrome Neurol\u00e9ptico Maligno\">Gesti\u00f3n y Tratamiento del S\u00edndrome Neurol\u00e9ptico Maligno<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#Prevencion_del_Sindrome_Neuroleptico_Maligno\" title=\"Prevenci\u00f3n del S\u00edndrome Neurol\u00e9ptico Maligno\">Prevenci\u00f3n del S\u00edndrome Neurol\u00e9ptico Maligno<\/a><ul class='ez-toc-list-level-4'><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#Preguntas_Frecuentes_FAQs\" title=\"Preguntas Frecuentes (FAQs)\">Preguntas Frecuentes (FAQs)<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Definicion_y_Criterios_Diagnosticos_del_Sindrome_Neuroleptico_Maligno_segun_el_DSM-5\"><\/span>Definici\u00f3n y Criterios Diagn\u00f3sticos del S\u00edndrome Neurol\u00e9ptico Maligno seg\u00fan el DSM-5<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Seg\u00fan la quinta edici\u00f3n del Manual Diagn\u00f3stico y Estad\u00edstico de Trastornos Mentales (<em>DSM-5<\/em>) de la Asociaci\u00f3n Americana de Psiquiatr\u00eda, el SNM se clasifica bajo el c\u00f3digo 333.92 o G21.0.<\/p>\n<ul>\n<li><strong>C\u00f3digo ICD-10-CM:<\/strong> G21.0 &#8211; Enfermedad inducida por drogas extrapiramidales y trastorno del movimiento.<\/li>\n<li><strong>C\u00f3digo ICD-9-CM:<\/strong> 333.92 &#8211; S\u00edndrome neurol\u00e9ptico maligno.<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Etiologia_y_Factores_de_Riesgo_para_Desarrollar_SNM\"><\/span>Etiolog\u00eda y Factores de Riesgo para Desarrollar SNM<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aunque cualquier individuo que toma antipsic\u00f3ticos puede desarrollar SNM, existen ciertos factores que pueden aumentar el riesgo.<\/p>\n<ol>\n<li><strong>Uso de antipsic\u00f3ticos de primera generaci\u00f3n:<\/strong> Estos medicamentos tienen un mayor riesgo de causar SNM en comparaci\u00f3n con los antipsic\u00f3ticos de segunda generaci\u00f3n.<\/li>\n<li><strong>Dosis altas y aumento r\u00e1pido:<\/strong> El inicio o la escalada r\u00e1pida de la dosis puede aumentar el riesgo.<\/li>\n<li><strong>Historia previa del SNM:<\/strong> Las personas que han experimentado SNM anteriormente tienen un mayor riesgo de recurrencia.<\/li>\n<\/ol>\n<h4><span class=\"ez-toc-section\" id=\"Sintomas_Clinicos_y_Diagnostico_del_Sindrome_Neuroleptico_Maligno\"><\/span>S\u00edntomas Cl\u00ednicos y Diagn\u00f3stico del S\u00edndrome Neurol\u00e9ptico Maligno<span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p>El diagn\u00f3stico del SNM se basa principalmente en la identificaci\u00f3n cl\u00ednica. Los s\u00edntomas m\u00e1s comunes incluyen hipertermia, rigidez muscular \u00aben tubo de plomo\u00bb, alteraciones auton\u00f3micas como sudoraci\u00f3n excesiva, presi\u00f3n arterial inestable y taquicardia, as\u00ed como cambios mentales tales como confusi\u00f3n o agitaci\u00f3n. Adem\u00e1s, pueden presentarse elevaciones en las pruebas sangu\u00edneas para creatina quinasa (CK) debido a da\u00f1o muscular y leucocitosis por respuesta inflamatoria sist\u00e9mica.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Gestion_y_Tratamiento_del_Sindrome_Neuroleptico_Maligno\"><\/span>Gesti\u00f3n y Tratamiento del S\u00edndrome Neurol\u00e9ptico Maligno<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cuando se sospecha SNM, es crucial interrumpir inmediatamente todos los medicamentos neurol\u00e9pticos. La gesti\u00f3n inicial debe centrarse en estabilizar al paciente m\u00e9dicamente e iniciar medidas para reducir la fiebre alta si est\u00e1 presente. En casos graves, puede ser necesario el ingreso en la unidad de cuidados intensivos.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Prevencion_del_Sindrome_Neuroleptico_Maligno\"><\/span>Prevenci\u00f3n del S\u00edndrome Neurol\u00e9ptico Maligno<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>La prevenci\u00f3n es un aspecto clave en el manejo del SNM. Esto incluye evitar el uso innecesario de antipsic\u00f3ticos, especialmente a dosis altas y aumentos r\u00e1pidos de dosis. Adem\u00e1s, los pacientes que han experimentado SNM anteriormente deben evitar estos medicamentos si es posible.<\/p>\n<h4><span class=\"ez-toc-section\" id=\"Preguntas_Frecuentes_FAQs\"><\/span>Preguntas Frecuentes (FAQs)<span class=\"ez-toc-section-end\"><\/span><\/h4>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li><strong>\u00bfQu\u00e9 causa el S\u00edndrome Neurol\u00e9ptico Maligno?<\/strong><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p>El SNM es causado por una reacci\u00f3n adversa a los medicamentos antipsic\u00f3ticos. Sin embargo, no todos los individuos que toman estos medicamentos desarrollar\u00e1n este s\u00edndrome.<\/p>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li><strong>\u00bfC\u00f3mo se diagnostica el S\u00edndrome Neurol\u00e9ptico Maligno?<\/strong><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p>No existe una prueba espec\u00edfica para diagnosticar SNM. El diagn\u00f3stico se basa principalmente en la identificaci\u00f3n cl\u00ednica de sus s\u00edntomas caracter\u00edsticos y la exclusi\u00f3n de otras posibles causas.<\/p>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li><strong>\u00bfCu\u00e1l es el tratamiento para el S\u00edndrome Neurol\u00e9ptico Maligno?<\/strong><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p>Cuando se sospecha SNM, lo m\u00e1s importante es interrumpir inmediatamente todos los medicamentos neurol\u00e9pticos. La gesti\u00f3n inicial debe centrarse en estabilizar al paciente m\u00e9dicamente e iniciar medidas para reducir la fiebre alta si est\u00e1 presente.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El S\u00edndrome Neurol\u00e9ptico Maligno (SNM) es una reacci\u00f3n adversa grave a los medicamentos antipsic\u00f3ticos, caracterizada por hipertermia, rigidez muscular y disfunci\u00f3n auton\u00f3mica severa. Definici\u00f3n y Criterios Diagn\u00f3sticos del S\u00edndrome Neurol\u00e9ptico Maligno seg\u00fan el DSM-5 Seg\u00fan la quinta edici\u00f3n del Manual Diagn\u00f3stico y Estad\u00edstico de Trastornos Mentales (DSM-5) de la Asociaci\u00f3n Americana de Psiquiatr\u00eda, el SNM &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/\" class=\"more-link\">Continuar leyendo<span class=\"screen-reader-text\"> \u00abS\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0)\u00bb<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":5494,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[19],"tags":[],"class_list":["post-5082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dsm"],"jetpack_publicize_connections":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.12 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0) - Psiquiatr\u00eda Madrid<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0) - Psiquiatr\u00eda Madrid\" \/>\n<meta property=\"og:description\" content=\"El S\u00edndrome Neurol\u00e9ptico Maligno (SNM) es una reacci\u00f3n adversa grave a los medicamentos antipsic\u00f3ticos, caracterizada por hipertermia, rigidez muscular y disfunci\u00f3n auton\u00f3mica severa. Definici\u00f3n y Criterios Diagn\u00f3sticos del S\u00edndrome Neurol\u00e9ptico Maligno seg\u00fan el DSM-5 Seg\u00fan la quinta edici\u00f3n del Manual Diagn\u00f3stico y Estad\u00edstico de Trastornos Mentales (DSM-5) de la Asociaci\u00f3n Americana de Psiquiatr\u00eda, el SNM &hellip; Continuar leyendo &quot;S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/\" \/>\n<meta property=\"og:site_name\" content=\"Psiquiatr\u00eda Madrid\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-19T03:36:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-20T10:49:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/psiquiatriamadrid.com\/wp-content\/uploads\/2024\/06\/sindrome-neuroleptico-maligno-333-92-g21-0.png\" \/>\n\t<meta property=\"og:image:width\" content=\"931\" \/>\n\t<meta property=\"og:image:height\" content=\"364\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/psiquiatriamadrid.com\/#\/schema\/person\/d1136533bc77372adb66643d6134e681\"},\"headline\":\"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0)\",\"datePublished\":\"2024-06-19T03:36:00+00:00\",\"dateModified\":\"2024-06-20T10:49:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/\"},\"wordCount\":545,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/psiquiatriamadrid.com\/#organization\"},\"articleSection\":[\"dsm\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/\",\"url\":\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/\",\"name\":\"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0) - Psiquiatr\u00eda Madrid\",\"isPartOf\":{\"@id\":\"https:\/\/psiquiatriamadrid.com\/#website\"},\"datePublished\":\"2024-06-19T03:36:00+00:00\",\"dateModified\":\"2024-06-20T10:49:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/psiquiatriamadrid.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/psiquiatriamadrid.com\/#website\",\"url\":\"https:\/\/psiquiatriamadrid.com\/\",\"name\":\"Psiquiatr\u00eda Madrid\",\"description\":\"Toda la informaci\u00f3n sobre la psiquiatr\u00eda y atenci\u00f3n de salud mental en Madrid\",\"publisher\":{\"@id\":\"https:\/\/psiquiatriamadrid.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/psiquiatriamadrid.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/psiquiatriamadrid.com\/#organization\",\"name\":\"Psiquiatr\u00eda Madrid\",\"url\":\"https:\/\/psiquiatriamadrid.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/psiquiatriamadrid.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/psiquiatriamadrid.com\/wp-content\/uploads\/2020\/02\/cropped-psiquiatria-icono-1.png\",\"contentUrl\":\"https:\/\/psiquiatriamadrid.com\/wp-content\/uploads\/2020\/02\/cropped-psiquiatria-icono-1.png\",\"width\":250,\"height\":250,\"caption\":\"Psiquiatr\u00eda Madrid\"},\"image\":{\"@id\":\"https:\/\/psiquiatriamadrid.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/psiquiatriamadrid.com\/#\/schema\/person\/d1136533bc77372adb66643d6134e681\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/psiquiatriamadrid.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/573f220cad701ed3cd22e40d865c4a36fafad94eebaad27817a24bf1c77e5abd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/573f220cad701ed3cd22e40d865c4a36fafad94eebaad27817a24bf1c77e5abd?s=96&d=mm&r=g\",\"caption\":\"admin\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0) - Psiquiatr\u00eda Madrid","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/","og_locale":"es_ES","og_type":"article","og_title":"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0) - Psiquiatr\u00eda Madrid","og_description":"El S\u00edndrome Neurol\u00e9ptico Maligno (SNM) es una reacci\u00f3n adversa grave a los medicamentos antipsic\u00f3ticos, caracterizada por hipertermia, rigidez muscular y disfunci\u00f3n auton\u00f3mica severa. Definici\u00f3n y Criterios Diagn\u00f3sticos del S\u00edndrome Neurol\u00e9ptico Maligno seg\u00fan el DSM-5 Seg\u00fan la quinta edici\u00f3n del Manual Diagn\u00f3stico y Estad\u00edstico de Trastornos Mentales (DSM-5) de la Asociaci\u00f3n Americana de Psiquiatr\u00eda, el SNM &hellip; Continuar leyendo \"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0)\"","og_url":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/","og_site_name":"Psiquiatr\u00eda Madrid","article_published_time":"2024-06-19T03:36:00+00:00","article_modified_time":"2024-06-20T10:49:39+00:00","og_image":[{"width":931,"height":364,"url":"https:\/\/psiquiatriamadrid.com\/wp-content\/uploads\/2024\/06\/sindrome-neuroleptico-maligno-333-92-g21-0.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#article","isPartOf":{"@id":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/"},"author":{"name":"admin","@id":"https:\/\/psiquiatriamadrid.com\/#\/schema\/person\/d1136533bc77372adb66643d6134e681"},"headline":"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0)","datePublished":"2024-06-19T03:36:00+00:00","dateModified":"2024-06-20T10:49:39+00:00","mainEntityOfPage":{"@id":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/"},"wordCount":545,"commentCount":0,"publisher":{"@id":"https:\/\/psiquiatriamadrid.com\/#organization"},"articleSection":["dsm"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/","url":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/","name":"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0) - Psiquiatr\u00eda Madrid","isPartOf":{"@id":"https:\/\/psiquiatriamadrid.com\/#website"},"datePublished":"2024-06-19T03:36:00+00:00","dateModified":"2024-06-20T10:49:39+00:00","breadcrumb":{"@id":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/psiquiatriamadrid.com\/index.php\/sindrome-neuroleptico-maligno-333-92-g21-0\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/psiquiatriamadrid.com\/"},{"@type":"ListItem","position":2,"name":"S\u00edndrome neurol\u00e9ptico maligno: 333.92 (G21.0)"}]},{"@type":"WebSite","@id":"https:\/\/psiquiatriamadrid.com\/#website","url":"https:\/\/psiquiatriamadrid.com\/","name":"Psiquiatr\u00eda Madrid","description":"Toda la informaci\u00f3n sobre la psiquiatr\u00eda y atenci\u00f3n de salud mental en Madrid","publisher":{"@id":"https:\/\/psiquiatriamadrid.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/psiquiatriamadrid.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/psiquiatriamadrid.com\/#organization","name":"Psiquiatr\u00eda Madrid","url":"https:\/\/psiquiatriamadrid.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/psiquiatriamadrid.com\/#\/schema\/logo\/image\/","url":"https:\/\/psiquiatriamadrid.com\/wp-content\/uploads\/2020\/02\/cropped-psiquiatria-icono-1.png","contentUrl":"https:\/\/psiquiatriamadrid.com\/wp-content\/uploads\/2020\/02\/cropped-psiquiatria-icono-1.png","width":250,"height":250,"caption":"Psiquiatr\u00eda Madrid"},"image":{"@id":"https:\/\/psiquiatriamadrid.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/psiquiatriamadrid.com\/#\/schema\/person\/d1136533bc77372adb66643d6134e681","name":"admin","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/psiquiatriamadrid.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/573f220cad701ed3cd22e40d865c4a36fafad94eebaad27817a24bf1c77e5abd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/573f220cad701ed3cd22e40d865c4a36fafad94eebaad27817a24bf1c77e5abd?s=96&d=mm&r=g","caption":"admin"}}]}},"jetpack_featured_media_url":"https:\/\/psiquiatriamadrid.com\/wp-content\/uploads\/2024\/06\/sindrome-neuroleptico-maligno-333-92-g21-0.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/posts\/5082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/comments?post=5082"}],"version-history":[{"count":2,"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/posts\/5082\/revisions"}],"predecessor-version":[{"id":5493,"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/posts\/5082\/revisions\/5493"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/media\/5494"}],"wp:attachment":[{"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/media?parent=5082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/categories?post=5082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psiquiatriamadrid.com\/index.php\/wp-json\/wp\/v2\/tags?post=5082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}